LB

Lakshmanasamy Balachandran

Director Director DIN 02904210
DIN 02904210 First appointment Feb 2010 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2010
Shareholding value •••• Premium profile

About Lakshmanasamy Balachandran

Data last updated:

Lakshmanasamy Balachandran was a Director at Indrakshi Pharma Private Limited (2010–2011) and Director at Nava Jeevan Medical Foundations Private Limited (2011–2013). The companies operate in Healthcare.

DIN 02904210
Primary Designation Director
Industry Healthcare
First Appointment 01 Feb 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indrakshi Pharma Private Limited U33125TN2009PTC070372
Director01 Feb 20102009Strike Off
Director31 Mar 20112011₹5.86 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indrakshi Pharma Private Limited
Nava Jeevan Medical Foundations Private Limited
Premium access

Shareholding and investment profile for Lakshmanasamy Balachandran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakshmanasamy Balachandran

Lakshmanasamy Balachandran was first appointed on 01 Feb 2010 as Director at Indrakshi Pharma Private Limited. The most recent appointment on record is 31 Mar 2011 at Nava Jeevan Medical Foundations Private Limited.

Lakshmanasamy Balachandran held 2 earlier board appointments: Indrakshi Pharma Private Limited (Director, 01 Feb 2010 to 15 Sep 2011); Nava Jeevan Medical Foundations Private Limited (Director, 31 Mar 2011 to 01 May 2013).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available